top of page
Subscribe
Latest
All News
Reports
Events
Directory
Contact
More
Use tab to navigate through the menu items.
Browse by category
All Posts
All News
Research
Spotlight
Industry & Products
Events & Training
Journal watch
Surgery News
Latest News
Top 10
Search
First patient treated in phase 2 obesity trial of GLY-200 polymer
Glyscend Therapeutics has initiated a Phase 2 clinical trial of its lead candidate, GLY-200, as a novel oral treatment for obesity....
Therapeutic polymer could provide alternative to gastric bypass
An orally administered therapeutic polymer, GLY-200, designed to bind to and enhance the barrier function of mucus in the...
Browse by tag
obesity
(326)
326 posts
bariatric surgery
(192)
192 posts
type 2 diabetes
(95)
95 posts
weight loss
(82)
82 posts
semaglutide
(63)
63 posts
bariatric and metabolic surgery
(62)
62 posts
SOARD
(47)
47 posts
glucagon-like peptide (GLP-1) analogues
(46)
46 posts
covid-19
(40)
40 posts
Obesity Surgery
(38)
38 posts
Journal watch
(37)
37 posts
childhood obesity
(34)
34 posts
adolescent obesity
(34)
34 posts
diabetes
(34)
34 posts
product launch
(27)
27 posts
laparoscopic sleeve gastrectomy
(27)
27 posts
weight gain
(27)
27 posts
pregnancy
(23)
23 posts
tirzepatide
(22)
22 posts
outcomes
(21)
21 posts
sleeve gastrectomy
(21)
21 posts
Researcher 2 Researcher and Bariatric News - The Podcasts
a few seconds ago
ESSENCE: Semaglutide effectively treats liver disease in two thirds of patients
2 hours ago
FDA accepts filing application for oral semaglutide 25mg
10 hours ago
Back to Top
bottom of page